Professional Documents
Culture Documents
S, Silumbe .M, Mapulanga .V, Kalo .K, Labib .M, Bowa .K University teaching Hospital, Department of Surgery, Urology Unit, Lusaka
We report on penile cancer patients presented to University Teaching Hospital (UTH), Lusaka for the period January 2008 to September 2010. UTH is a tertially highest referral Hospital in Zambia. Patients are referred from all the nine provinces in Zambia for specialist Treatment. It serves a population of over two point five (2.5) million. Most patients with penile cancer present with advanced disease to the hospital due to various reasons. The delay may be attributed to embarrassment, guilty, fear, ignorance and personal neglect. Patients often try to treat themselves with various skin creams and lotions, this may appear to be effective for a time, which further delays the diagnosis and worsen the prognosis. Keywords: Penile cancer, Tumour, Sexually Transmitted Diseases (STDS), Human Immunodeficiency Virus (HIV), Treatment option, Circumcision, Squamous Cell Carcinoma (SCC), Suprapubic cystostomy (SPC). Correspondence to: Dr Mukosai S ,Department of Surgery, Urology Unit, University Teaching Hospital ,P/B Rw1x, Lusaka. Zambia, Tel +260977848960, Email; smukosai@yahoo.com. Abstract Introduction Penile cancer is an uncommon malignancy in developed countries. In the United States, 1,530 cases occur per year. It accounts for 0.4 to 0.6% of all malignancies in the United States and Europe [1]. Penile cancer represents 20 to 30% of all cancers diagnosed in men who live in Africa, Asia, and South America [1]. Most Penile cancer commonly affects men between 50 and 70 years of age (Hopmann and Fraley 1978). Younger individuals are also affected; approximately 22% of patients are less than 40 years of age. It accounts for two to five percents of genitourinary malignancies [2]. Around 4000 cases are diagnosed each year. Predisposing factors include; Poor hygiene, lack of circumcision, phimosis infection by Human papillomavirus (HPV). Commonly found in men in their 6th decade, more in blacks than whites 2:1[1]. Treatment involves surgical resection with or without inguinal lymph node dissection. Prognosis depends on stage and grade of the tumour [3]. Patients and Methods: Twenty four patients were diagnosed with penile cancer between September 2008 and September 2010. All patients records were retrieved and the data recorded included the Jackson staging, histological grade and treatment option. End points were death, nodal progression, and local recurrence and lost to follow up.
Conclusion: The defining features of patients and disease in this series are significantly different to published series in Europe and America. The is also significant variability in the treatment modalities used in this series. Intemational data on penile cancer are retrospective and inconclusive with regard to best practice. There is an urgent requirement for randomized controlled trials to improve the outcome of these patients.
Case Series Report Table 1 Code Clinical Presentation Age STI Hx yes HIV Circum Histology Statu cised s _ No SCC Operation Out come Recurr ence & Died Died Lost to follow up Lost to follow Lost to follow up Lost to follow up Lost to follow up Lost to follow up Lost to follow up Lost to follow up Lost to follow up Lost to follow
001
50
Partial Penectomy
002 003
Infected hard scrotal mass involving urethral Fungating foul mass distal penis, Inguinal LN+ 6/12 History of penile ulcer, inguinal Lymph node negative 8/12 Hx of Fungating penile mass eroding glans, shaft proximally 4/12 Hx of fungating mass on prepuce, glands penile shaft, inguinal LN+ fixed 10/12 Hx of fungating penile mass glans,prepuce Penile ulcer on glands
50 36
yes yes
+ +
No No
Resection + Radiotherapy Declined operation Partial Penectomy Total penectomy Total Penectomy Partial penectomy Excision
004
47
yes
No
005
52
No
No
SCC
006
70
yes
No
SCC
007
45
yes
No
SCC
008
39
yes
No
SCC
009
010
Fungating penile mass eroding glands, penile shaft, inguinal LN+ fixed Fungating penile mass ,prepuce & glands Fungating mass on prepuce & glands Penile ulcer on gland
57
yes
yes
SCC
47
No
N A +
No
SCC
011
40
yes
No
SCC
012
50
NA
yes
SCC
013
8/12 Hx of Fungating penile mass distal penis 6/12 Hx of wart-like growth on prepuce & glands 9/12 Hx of growth distal penis- prepuce, glands, inguinal LN+ Penile fungating mass
47
yes
No
SCC
Total amputation Excision Biopsy Partial Amputation Penile amputation Partial Amputation Partial amputation Partial penectomy Penectomy
014
72
NA
No
SCC
015
59
No
N A -
No
SCC
016
64
NA
Un known No
SCC
017
58
NA
NA
018
Penile mass
78
NA
N A +
Un known No
NA
019
53
yes
SCC
020
Penile mass
55
NA
Un known No Un known No
SCC
021 022
42 80
yes NA
+ -
SCC SCC
023
024
Fungating penile tumour prepuce,glans & distal penile shaft, inguinal LN+ Fungating penile mass
72
NA
SCC
38
yes
Un known
SCC
up Lost to follow up Nodal progre ssion Lost to follow up Lost to follow up Lost to follow up Lost to follow up Lost to follow up Lost to follow up Lost to Lost to follow up Lost to follow up Died
Eight (33.3%) patients were HIV positive and in three patients their HIV status was not documented shown in table 1. Eight Twenty (83%) of the patients were lost follow up. Thirteen (54.2%) has had history of STI before as shown in table 1.
Table 2 Age variation in penile cancer at UTH, 2008-2010 Age group in years 0-40 41-50 51-60 61-70 71-80 No. penile cancer 4 8 6 2 4 % Total 16.7 33.3 25 8.3 16.7
The age range was 38 to 80 years with the mean of 54 years and peak in the 41 to 50 year old groups as depicted in table 2 above.
Table 3 Anatomical distribution in penile cancer patients at UTH for period 2008 to 2010 Site of primary lesion Gland penis Gland & shaft penis Prepuce only Whole penis & scrotum Total No. of patients 4 14 2 4 24 % Total 16.3 58.3 8.3 16.3 100
The anatomical distribution indicates that 14 (58.3%) had glandular penile cancer with spread to the shaft, while 2 (8.3%) had cancer restricted the prepuce as shown in table 3.
Table 4 Circumcision status in penile cancer at UTH [2008-2010 Circumcision status Total Uncircumcised Circumcised as neonate Circumcision status unknown Circumcised as adult, adolescent, infant Total No. of Patients %
17 0 5 2 24
Table 4 shows 17(70.8%) patients were uncircumcised and none were circumcised during neonate period. Two (8.3%) were circumcised during their adult or adolescent period. Table 5 Clinical stage of penile cancer at UTH [2008-2010] Jackson classification stage I II III IV No. of patients 2 2 14 6 % Total 8.3 8.3 58.3 25
Twenty patients had advanced disease (Jacksons stage III and IV) as shown in Table 5.
Table 6 Demographic pattern of patients with penile cancer at UTH Province Distance from Lusaka No. of patients Percentage (%) (Km) 500 850 400 450 800 600 650 0 800
Eastern Northern Central Copper belt Luapula Western Southern Lusaka North western
4 2 2 3 2 3 3 5 0
Majority of patients with penile cancer five (20.8%) came from Lusaka. The was no patient with penile cancer from Northwestern Province during period under review.
Discussion Penile cancer is relatively rare; other studies in parts of Africa, Uganda have shown its presence in only 3.5% were circumcision is not practiced [3]. Elshleman also reported penile cancer in only 4.0% of all malignant tumours reviewed at Shirati hospital in northern Tanzania [4]. Burkitt in 1965 reported cancer of the penis to be uniformly rare in some uncircumcised Ugandan tribes such as the Acholi and the Lugbara and some tribes of the southern highlands of Tanzania [5]. In our study the age range was 38 80 years with a mean of 54 years and peak incidence of 41- 50 year age groups which is not in conformity to other reported case series in Europe and America [60-65 years] [12]. It is however widely reported that squamous cell cancer of the penis is commoner in men in their sixth and seventh decades with an abrupt increase in incidence at 60 years and peaking at 80 years of age [6]. Cancer of the penis is usually an epidermoid tumour arising from the glans penis or the mucosal lining of the prepuce [7]. In this case series the majority 14 (58.3%) had glandular with spread to the penile shaft. The majority (58.3%) presented with advanced disease with either operable or inoperable inguinal lymphadenophy. The reason for this late presentation of penile cancer in this locality is due to the delay in seeking appropriate medical advice as a result of socio-cultural taboos and ignorance. The majority of patients (70.8%) were uncircumcised .This is in conformity with evidence that penile cancer is said to be common among uncircumcised males [8]. The development of tumour in the uncircumcised men has been attributed to the chronic irritative effects of smegma, a by product of bacterial action on desquamated cells that are within the preputial sac. Such exposure is accentuated by phimosis which is present in 25- 75% of patients in most large series [9]. Neonatal circumcision as practiced by the Jews is known to prevent the development of cancer of penis [10]. However, circumcision in adolescence and in adults does not prevent the development of penile cancer [11]. Sixteen patients had partial penectomy as a form of treatment while three had total penectomy with perineal urethrostomy. One patient declined surgery and was lost to follow up. Further more only one patient received palliative care due to terminally advanced penile disease. Twenty (83%) of the patients were lost to follow up and this could be attributed to the far to reach locations of these patients and poor economic status. The low incidence of penile cancer in North western Province could be attributed to the practice of male circumcision which is done as part of their tradition in early childhood. Conclusion The is variability in the patients and their defining features of their tumours in this case series with published data in Europe and America. The is also comparable variability in the treatment offered in this case series for each particular stage of penile cancer. This series does not have the power to determine guidelines. There remains a need for prospective, randomised, controlled trials (multicentre, in view of the scarcity of the disease) to clarify treatment options.
References 1. Stanley .A at el, 2008, Penile Cancer, emedicine.medscape.com 2. Thomson I.M and Fair WR, Penile Carcinoma, AUA Update Ser.1990; 9; 1-8 3. Barnholtz-Sloan JS, Maldonado JL, Pow-sang J, Guiliano AR. Incidence trends in primary malignant penile cancer. Urol Oncol. 2007; 25:361-367. 4. American Cancer Society. Cancer Facts & Figures 2008. Atlanta: American Cancer Society; 2008. 5. Pettaway CA, Lynch DF, Davis JW. Tumors of the penis. In: Campbell-Walsh Urology, 9th ed. Philadelphia: Saunders Elsevier; 2007:959-992. 6. Swartz MA, Porter MP, Lin DW, Weiss NS. Incidence of primary urethral carcinoma in the United States. Urology. 2006; 68:1164-1168. 7. Castellsague X, Bosch FX, Munoz N, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. NEJM. 2002; 346:1105-1112. 8. Gilliland F, Key CR. Male genital cancer. Cancer. 1995; 75:295-315. 9. Martinez I. Relationship of squamous cell carcinoma of the cervix uteri to squamous cell carcinoma of the penis among Puerto Rican women married to men with penile cancer. Cancer. 1969; 24:777. 10. Gross G, Pfister H. Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol (Berlin). 2004;193:35-44. 11.. Daling JR, Madeleine MM, Johnson LG, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005; 116:606-615. 12.Theodorescu D, Russo P, Zhang ZF, Morash C, Fair WR. Outcomes of initial surveillance of invasive cell carcinoma of the penis and negative nodes. J Urol 1996; 155: 1626-31.